
    
      Bevacizumab administered at 15 mg/kg on day 1 of each of 6 cycles

      Rituximab administered 375 mg/m2 on day 3 of each of 6 cycles (with usual premedications)

      Standard CHOP chemotherapy administered on day 3 every 21 days (full dose) for 6 cycles of
      treatment

      Once completed six cycles of therapy (~18 weeks), patients will be evaluated every 3 months
      for the first year post treatment, then every 6 months until disease progression or death for
      years 2 through 5 post treatment. Patients who have disease progression will be contacted
      every 6 months until death to assess for survival status.
    
  